-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Boston Scientific, Lowers Price Target to $44

Benzinga·10/29/2026 19:23:05
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Neutral and lowers the price target from $48 to $44.